ISRG
Intuitive Surgical, Inc.
ISRG has the edge over UNH overall, supported by stronger fundamentals and stronger valuation.
UNH
UnitedHealth Group Incorporated
UNH's outlook is improving, though it still trails on the overall score.
ISRG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
ISRG's revenue, profitability, cash flow and balance sheet are all currently healthy.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ISRG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 36x | $440 | — |
| Cheap | 52x | $429 | -2.5% |
| Current | 53x | $440 | — |
| Fair | 72x | $596 | +36% |
| Expensive | 84x | $691 | +57% |
Historical ranges are pointers, not guarantees.
ISRG has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
ISRG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| High |
ISRG has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
ISRG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.09 | +47% |
| Q3 2026 | $8.25 | +9% |
| Q2 2026 | $8.71 | +21% |
| Q1 2026 | $8.23 | +20% |
| Q4 2025 | $7.87 | +23% |
| Q3 2025 | $7.57 | +22% |
| Q2 2025 | $7.18 | +23% |
| Q1 2025 | $6.83 | +23% |
| Q4 2024 | $6.42 | +28% |
ISRG has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
ISRG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3B | +22% |
| Q2 2026 | $2.9B | +19% |
| Q1 2026 | $2.8B | +23% |
| Q4 2025 | $2.9B | +19% |
| Q3 2025 | $2.5B | +23% |
| Q2 2025 | $2.4B | +21% |
| Q1 2025 | $2.3B | +19% |
| Q4 2024 | $2.4B | +25% |
ISRG has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | -11 points |
| Q2 2026 | 34% | +3.1 points |
| Q1 2026 | 31% | +5.2 points |
| Q4 2025 | 30% | -0.3 points |
| Q3 2025 | 30% | +2 points |
| Q2 2025 | 30% | +2.2 points |
| Q1 2025 | 26% | +0.8 points |
| Q4 2024 | 30% | +7.1 points |
ISRG has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
ISRG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +51% |
| Q2 2026 | $948.4M | +69% |
| Q1 2026 | $808.6M | +74% |
| Q4 2025 | $730M | +43% |
| Q3 2025 | $735.6M | +60% |
| Q2 2025 | $560.1M | +80% |
| Q1 2025 | $465M | +1879% |
| Q4 2024 | $510.6M | +$717.8M |
ISRG has the edge over UNH on cash flow, with more consistent year-over-year improvement.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
ISRG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -5.7M shares |
| 1 year | -2.8% | -10.2M shares |
| 3 years | -1.8% | -6.6M shares |
| 5 years | -4.1% | -15.2M shares |
| Available history | -1.9% | -6.9M shares |
ISRG has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $320.3M |
| Q1 2026 | $1.1B |
| Q4 2025 | $201M |
| Q3 2025 | $1.9B |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
ISRG spent $4.6B buying back its own shares over the past year.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
ISRG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -0.6x | Net Cash |
| Q3 2021 | -0.6x | Net Cash |
| Q2 2021 | -0.9x | Net Cash |
| Q1 2021 | -1.0x | Net Cash |
| Q4 2020 | -1.2x | Net Cash |
| Q3 2020 | -1.1x | Net Cash |
| Q2 2020 | -1.5x | Net Cash |
| Q1 2020 | -0.8x | Net Cash |
ISRG has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
ISRG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.7 | Neutral |
| Stochastic | 73.5 | Neutral |
ISRG's weekly RSI is 55 (neutral) and its Stochastic is 74 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
ISRG PE vs Healthcare Sector
| Metric | ISRG | Sector median | Relative |
|---|---|---|---|
| PE | 53x | 26x | 106% above |
| PE % | 19 | 29 | 10 pts below |
ISRG is trading at 53x earnings, a 106% premium to the Healthcare sector's median of 26x.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over ISRG on valuation relative to its sector.
ISRG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $428.1 | 2.8% above |
| 20 week MA | $397.4 | 11% above |
| 50 week MA | $449.8 | 2.2% below |
| 100 week MA | $483.9 | 9.1% below |
| 200 week MA | $424.9 | 3.5% above |
ISRG's trend is mixed: it's above three of its five weekly moving averages, and 3.5% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over ISRG on trend strength, trading above more of its moving averages.
ISRG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $199.3 | $269.0 | +35% |
| 2021 | $269.0 | $363.9 | +35% |
| 2022 | $363.9 | $262.7 | -28% |
| 2023 | $262.7 | $337.4 | +28% |
| 2024 | $337.4 | $534.9 | +59% |
| 2025 | $534.9 | $577.8 | +8% |
| 2026 YTD | $577.8 | $439.9 | -24% |
ISRG has finished higher in five of the last six years. It's down 24% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over ISRG on returns for 2026, with the stronger performance.